🇺🇸 FDA
Patent

US 11116740

Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome

granted A61KA61K31/20A61K31/201

Quick answer

US patent 11116740 (Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome) held by United States of America as represented by the Secretary of the Air Force expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/20, A61K31/201, A61K31/202, A61P